Anne Gussow

Array ( [id] => 6245617 [patent_doc_number] => 20100135996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'MONOCLONAL ANTIBODIES AND FRAGMENT THEREOF DIRECTED AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II)' [patent_app_type] => utility [patent_app_number] => 12/513248 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16980 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135996.pdf [firstpage_image] =>[orig_patent_app_number] => 12513248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873661 [patent_doc_number] => 20080200395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation' [patent_app_type] => utility [patent_app_number] => 11/980325 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6327 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200395.pdf [firstpage_image] =>[orig_patent_app_number] => 11980325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820419 [patent_doc_number] => 20080226628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/926684 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 12840 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11926684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295996 [patent_doc_number] => 20090010922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE' [patent_app_type] => utility [patent_app_number] => 11/924890 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 57270 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010922.pdf [firstpage_image] =>[orig_patent_app_number] => 11924890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328833 [patent_doc_number] => 08236931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Prevention of aggregation of immunoglobulin light or heavy chains' [patent_app_type] => utility [patent_app_number] => 12/447908 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29123 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12447908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711985 [patent_doc_number] => 08093068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Methods for use in human-adapting monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/924094 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 5419 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093068.pdf [firstpage_image] =>[orig_patent_app_number] => 11924094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751976 [patent_doc_number] => 20080160049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Tissue Vaccines and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/924459 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7111 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160049.pdf [firstpage_image] =>[orig_patent_app_number] => 11924459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702626 [patent_doc_number] => 08088379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Modified T cell receptors and related materials and methods' [patent_app_type] => utility [patent_app_number] => 12/443111 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17740 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088379.pdf [firstpage_image] =>[orig_patent_app_number] => 12443111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711640 [patent_doc_number] => 20080300166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Treatment of Melanoma with Alpha Thymosin Peptides' [patent_app_type] => utility [patent_app_number] => 11/858640 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4765 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300166.pdf [firstpage_image] =>[orig_patent_app_number] => 11858640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272473 [patent_doc_number] => 20090076249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Antibodies against CD38 for treatment of multiple myeloma' [patent_app_type] => utility [patent_app_number] => 11/901953 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 94765 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076249.pdf [firstpage_image] =>[orig_patent_app_number] => 11901953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663125 [patent_doc_number] => 20080254032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Antibodies to M-CSF' [patent_app_type] => utility [patent_app_number] => 11/894560 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39600 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254032.pdf [firstpage_image] =>[orig_patent_app_number] => 11894560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74649 [patent_doc_number] => 07750125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 11/892017 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 137984 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750125.pdf [firstpage_image] =>[orig_patent_app_number] => 11892017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520900 [patent_doc_number] => 20090028881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Conjugate of an antibody against CCR5 and an antifusogenic peptide' [patent_app_type] => utility [patent_app_number] => 11/893899 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15606 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028881.pdf [firstpage_image] =>[orig_patent_app_number] => 11893899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745235 [patent_doc_number] => 20080089837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/833473 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 154232 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089837.pdf [firstpage_image] =>[orig_patent_app_number] => 11833473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771405 [patent_doc_number] => 20080057063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Antibodies Directed to AlphaVBeta6 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/833486 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 48370 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057063.pdf [firstpage_image] =>[orig_patent_app_number] => 11833486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277977 [patent_doc_number] => 20090130109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'DCL-1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/888911 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26678 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130109.pdf [firstpage_image] =>[orig_patent_app_number] => 11888911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 220867 [patent_doc_number] => 07608413 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-27 [patent_title] => 'Kidney disease targets and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/878050 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42721 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608413.pdf [firstpage_image] =>[orig_patent_app_number] => 11878050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432344 [patent_doc_number] => 07897351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Peptides and antibodies to MUC 1 proteins' [patent_app_type] => utility [patent_app_number] => 11/779012 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 8362 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897351.pdf [firstpage_image] =>[orig_patent_app_number] => 11779012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519034 [patent_doc_number] => 07973135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Compositions and methods for targeting cancer-specific transcription complexes' [patent_app_type] => utility [patent_app_number] => 11/777271 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16010 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973135.pdf [firstpage_image] =>[orig_patent_app_number] => 11777271 [rel_patent_id] =>[rel_patent_doc_number] =>)